Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengmeng Wang

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
International Journal of Biological Sciences|September 14, 2023
Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinomaJinfang Cui, Yuchao He, Fuyi Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 21, 2023
The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular CarcinomaYuchao He, Linlin Zhan, Jian Shi, et al.
Cell Reports. Medicine|November 6, 2025
Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapyYuan Gao, Yuchao He, Chengmeng Wang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
International Journal of Biological Sciences|September 14, 2023
Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinomaJinfang Cui, Yuchao He, Fuyi Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 21, 2023
The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular CarcinomaYuchao He, Linlin Zhan, Jian Shi, et al.
Cell Reports. Medicine|November 6, 2025
Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapyYuan Gao, Yuchao He, Chengmeng Wang, et al.
Pageof 2